Arvee Laboratories (India) Ltd.
NSE: ARVEE
₹169.00
₹-1.59
(-0.93%)
As on 28-Aug-2026IST
Market cap
₹186 Cr
Revenue (TTM)
₹41 Cr
P/E Ratio
46
P/B Ratio
5.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹4 Cr
-
ROE
7.1 %
-
ROCE
10 %
-
Industry P/E
36.92
-
EV/EBITDA
30.5
-
Debt to Equity
0
-
Book Value
₹32.2
-
EPS
₹3.7
-
Face value
10
-
Shares outstanding
11,020,000
10 Years Aggregate
CFO
₹48.15 Cr
EBITDA
₹55.17 Cr
Net Profit
₹19.96 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Arvee Laboratories
| -20.8 | 6.8 | 5.6 | 5.1 | 17.0 | 12.7 | -- |
|
BSE Commodities
| 9.7 | 2.7 | -1.2 | 13.5 | 16.4 | 9.7 | 14.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Arvee Laboratories
| 21.2 | 0.3 | 33.4 | 48.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Arvee Laboratories
|
169.0 | 186.2 | 41.3 | 4.1 | 9.9 | 12.4 | 46 | 5.2 |
| 540.4 | 19,601.8 | 9,013.0 | 531.0 | 9.4 | 9 | 36.9 | 3.2 | |
| 1,696.8 | 22,521.3 | 1,223.9 | 235.2 | 25.4 | 10 | 95.8 | 9.0 | |
| 1,260.4 | 14,311.5 | 2,534.6 | 225.0 | 15.7 | 5.4 | 81.9 | 4.3 | |
| 1,762.9 | 24,046.8 | 8,574.8 | 783.4 | 12.8 | 14 | 30.7 | 3.9 | |
| 5,282.5 | 16,175.3 | 2,471.6 | 442.5 | 19.3 | 17 | 36.9 | 5.8 | |
| 7,224.5 | 16,798.7 | 2,258.2 | 387.9 | 19.9 | 15 | 43.3 | 6.0 | |
| 683.5 | 10,919.5 | 4,650.6 | 308.8 | 9.4 | 10.3 | 35.4 | 3.4 | |
| 3,458.0 | 13,515.1 | 2,671.1 | 342.0 | 19.5 | 26.4 | 38.6 | 9.0 | |
| 1,325.2 | 13,730.0 | 2,380.8 | 448.4 | 23.0 | 14.7 | 30.6 | 4.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Arvee Laboratories
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono... lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4"amino pyridine, and 2"chloro"5"nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India. Read more
-
Incorporated
2012
-
Chairman
Shalin Sudhakarbhai Patel
-
Managing Director
Shalin Sudhakarbhai Patel
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Arvee Laboratories (India) Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Arvee Laboratories
What is the current share price of Arvee Laboratories (India) Ltd Today?
The share price of Arvee Laboratories (India) Ltd is ₹169.00 (NSE) as of 28-Aug-2026 IST. Arvee Laboratories (India) Ltd has given a return of 17.01% in the last 3 years.
What is the current PB & PE ratio of Arvee Laboratories (India) Ltd?
The P/E ratio of Arvee Laboratories (India) Ltd is 46.01 times as on 28-Aug-2026, a 25 premium to its peers’ median range of 36.92 times.
The P/B ratio of Arvee Laboratories (India) Ltd is 5.25 times as on 28-Aug-2026, a 88 premium to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
72.87 |
5.01 |
2024 |
150.24 |
5.43 |
2023 |
23.54 |
3.46 |
2022 |
48.68 |
5.23 |
2021 |
22.80 |
2.86 |
What is the 52 Week High and Low of Arvee Laboratories (India) Ltd?
The 52-week high and low of Arvee Laboratories (India) Ltd are Rs 290.78 and Rs 129.11 as of 30-Aug-2026.
What is the market cap of Arvee Laboratories (India) Ltd?
Arvee Laboratories (India) Ltd has a market capitalisation of ₹ 186 Cr as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Arvee Laboratories (India) Ltd?
Before investing in Arvee Laboratories (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.